These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9869781)

  • 21. Doxorubicin induced dilated cardiomyopathy in a rabbit model: an update.
    Gava FN; Zacché E; Ortiz EM; Champion T; Bandarra MB; Vasconcelos RO; Barbosa JC; Camacho AA
    Res Vet Sci; 2013 Feb; 94(1):115-21. PubMed ID: 22902286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary omega-3 supplementation exacerbates left ventricular dysfunction in an ovine model of anthracycline-induced cardiotoxicity.
    Carbone A; Psaltis PJ; Nelson AJ; Metcalf R; Richardson JD; Weightman M; Thomas A; Finnie JW; Young GD; Worthley SG
    J Card Fail; 2012 Jun; 18(6):502-11. PubMed ID: 22633309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of CardiPro against doxorubicin-induced cardiotoxicity in mice.
    Mohan IK; Kumar KV; Naidu MU; Khan M; Sundaram C
    Phytomedicine; 2006 Mar; 13(4):222-9. PubMed ID: 16492523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular volume reduction for dilated cardiomyopathy.
    Calafiore AM; Gallina S; Di Mauro M
    Ital Heart J; 2001 May; 2(5):323-5. PubMed ID: 11392634
    [No Abstract]   [Full Text] [Related]  

  • 25. Rat Model of Cardiotoxic Drug-Induced Cardiomyopathy.
    Nakahara T; Tanimoto T; Petrov AD; Ishikawa K; Strauss HW; Narula J
    Methods Mol Biol; 2018; 1816():221-232. PubMed ID: 29987823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective left ventricular adriamycin-induced cardiomyopathy in the pig.
    Christiansen S; Perez-Bouza A; Schälte G; Hilgers RD; Autschbach R
    J Heart Lung Transplant; 2008 Jan; 27(1):86-92. PubMed ID: 18187092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxorubicin-induced cardiac mitochondrionopathy.
    Wallace KB
    Pharmacol Toxicol; 2003 Sep; 93(3):105-15. PubMed ID: 12969434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On decreasing distal endothelial damage after intracoronary shunt insertion.
    Demaria RG; Perrault LP
    Ann Thorac Surg; 2005 May; 79(5):1826. PubMed ID: 15855002
    [No Abstract]   [Full Text] [Related]  

  • 29. Case presentation of doxorubicin-induced cardiomyopathy: a short- and long-term side effect of pediatric cancer treatment.
    Dunn J
    J Pediatr Oncol Nurs; 1991 Apr; 8(2):84. PubMed ID: 1675089
    [No Abstract]   [Full Text] [Related]  

  • 30. Stabilization of chronic remodeling by asynchronous cardiomyoplasty in dilated cardiomyopathy: effects of a conditioned muscle wrap.
    Patel HJ; Polidori DJ; Pilla JJ; Plappert T; Kass D; St John Sutton M; Lankford EB; Acker MA
    Circulation; 1997 Nov; 96(10):3665-71. PubMed ID: 9396469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does a suitable animal model for research on partial left ventriculectomy exist? Animal models for PLV.
    Christiansen S; Jahn UR; Stypmann J; Redmann K; Scheld HH; Hammel D
    Thorac Cardiovasc Surg; 2001 Oct; 49(5):259-67. PubMed ID: 11605134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally occurring cardiomyopathy in the Doberman pinscher: a possible large animal model of human cardiomyopathy?
    Smucker ML; Kaul S; Woodfield JA; Keith JC; Manning SA; Gascho JA
    J Am Coll Cardiol; 1990 Jul; 16(1):200-6. PubMed ID: 2358594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term survival after heart transplantation for doxorubicin induced cardiomyopathy.
    Aricò M; Pedroni E; Nespoli L; Viganò M; Porta F; Burgio GR
    Arch Dis Child; 1991 Aug; 66(8):985-6. PubMed ID: 1929498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of isoflurane and halothane on left ventricular afterload in dogs with dilated cardiomyopathy.
    Hettrick DA; Pagel PS; Kersten JR; Lowe D; Warltier DC
    Anesth Analg; 1997 Nov; 85(5):979-86. PubMed ID: 9356087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of heart failure: haemodynamic comparison of three different canine models.
    Djelmami-Hani M; Kazemi S; Hare J; Chekanov VS
    Lab Anim; 2007 Jan; 41(1):63-70. PubMed ID: 17234051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes.
    O'Connell JL; Romano MM; Campos Pulici EC; Carvalho EE; de Souza FR; Tanaka DM; Maciel BC; Salgado HC; Fazan-Júnior R; Rossi MA; Simões MV
    Exp Toxicol Pathol; 2017 Apr; 69(4):213-219. PubMed ID: 28153388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats.
    Ammar el-SM; Said SA; El-Damarawy SL; Suddek GM
    Pharm Biol; 2013 Mar; 51(3):339-44. PubMed ID: 23134235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy.
    Power JM; Raman J; Dornom A; Farish SJ; Burrell LM; Tonkin AM; Buxton B; Alferness CA
    Cardiovasc Res; 1999 Dec; 44(3):549-55. PubMed ID: 10690287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acute dynamic cardiomyoplasty in a goat model of chronic ventricular dilatation: part 1.
    Bolotin G; Lorusso R; Schreuder JJ; Kaulbach HG; Uretzky G; van der Veen FH
    Ann Thorac Surg; 2002 Aug; 74(2):507-13. PubMed ID: 12173837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart rate dynamics in doxorubicin-induced cardiomyopathy.
    Lončar-Turukalo T; Vasić M; Tasić T; Mijatović G; Glumac S; Bajić D; Japunžić-Žigon N
    Physiol Meas; 2015 Apr; 36(4):727-39. PubMed ID: 25798626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.